GlassScriptPhysician profile
Robert A Udesky
NPI 1205856754
$1,266.90
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $586 · 2020: $292 · 2021: $146 · 2022: $244.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $250.12 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $222.53 | 2019-2022 | |
| Intercept Pharmaceuticals, INC. | $73.49 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $67.16 | 2019-2020 | |
| Novo Nordisk INC | $65.92 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.65 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $56.40 | 2019 | |
| Amgen INC. | $52.26 | 2019 | |
| Pfizer INC. | $46.24 | 2019-2021 | |
| Glaxosmithkline, LLC. | $45.99 | 2019-2022 | |
| Incyte Corporation | $42.90 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.51 | 2019-2021 | |
| Sanofi Pasteur INC. | $23.00 | 2019 | |
| Janssen Biotech, INC. | $21.09 | 2022 | |
| Dova Pharmaceuticals | $19.19 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $18.98 | 2019 | |
| Lilly USA, LLC | $18.46 | 2020 | |
| Boston Scientific Corporation | $17.42 | 2022 | |
| Bardy Diagnostics, INC. | $17.00 | 2022 | |
| Therapeuticsmd, INC. | $16.80 | 2020 | |
| Gilead Sciences, INC. | $16.67 | 2020 | |
| Genentech USA, INC. | $16.50 | 2020 | |
| Bausch Health US, LLC | $16.36 | 2020 | |
| Linus Health, INC. | $15.87 | 2022 | |
| Endo Pharmaceuticals INC. | $14.90 | 2019 | |
| Allergan, INC. | $13.49 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Udesky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.